What can be a treatment-related change observed in pediatric leukemia patients?

• A. Gingival hyperplasia
• B. Increased tooth sensitivity
• C. Wear of enamel
• D. Malocclusion development

Answer: (A)

Gingival hyperplasia is a treatment-related change commonly observed in pediatric leukemia patients, particularly as a consequence of chemotherapy and certain medications used in their treatment regimen, such as phenytoin and some oral chemotherapeutics. This condition manifests as an overgrowth of gum tissue, which can be exacerbated by poor oral hygiene often present in these patients due to the effects of their illness and treatment side effects, such as mucositis.

Chemotherapy can weaken the immune system, making children more susceptible to infections, including gingival infections, which can further contribute to gingival overgrowth. Moreover, the inflammatory response to the existing bacteria in the oral cavity may lead to increased gingival tissue.

Monitoring for signs of gingival hyperplasia is vital for pediatric patients undergoing leukemia treatment, as proper dental care and hygiene can mitigate the severity of this side effect. Hence, the identification and management of gingival hyperplasia are critical components of dental care for children with leukemia during and following their treatment.